Project 4 is a new project of HL 42550, whose long-term objective is to delineate the mechanisms that are responsible for the recent observation that pro-inflammatory cytokines that signal through the tumor necrosis factor (TNF) receptors or the gp130 family of receptors confer cytoprotective /anti-apoptotic effects in cardiac myocytes. To this end the immediate specific objectives of Project 4 will be to delineate the mechanisms for the cytoprotective effects of these cytokines in the setting of experimental myocardial ischemia/reperfusion (I/R) injury.
Specific Aim 1 will test the hypothesis that reactive oxygen intermediates induced during I/R injury in mice are responsible for provoking cardiac myocyte apoptosis through mitochondrial dysfunction, release of cytochrome c, increased activity of caspases 9 and 3, and DNA degradation.
Specific Aim 2 will test the hypothesis that TNF protects against I/R induced myocyte apoptosis by attenuating and/or preventing mitochondrial dysfunction, by examining the effects of I/R injury in transgenic mice with low levels of cardiac restricted over-expression of TNF and knockout mice both TNF receptors.
Specific Aim 3 will test the hypothesis that the cytoprotective effects of TNF are mediated by TNF receptor associated factor 2 (TAF2), by examining the effects of I/R injury in transgenic mice with conditional over-expression of a TRAF2 dominant negative construct.
Specific Aim 4 will test the hypothesis that activation of the gp130 pathway protects the adult cardiac myocyte against I/R induced apoptosis by attenuating the activity of caspases 9 and 3, and that the cytoprotective effects of the gp130 injury in transgenic mice with cardiac restricted expression of leukemia inhibitory factor and mice with a ventricular restricted knockout of gp130. The above studies will be conducted in a Langerdorff buffer perfusion model of global I/R injury, a closed-chest model of I/R injury, and in isolated murine cardiac myocyte model subjected to hypoxia/reoxygenation. Taken together, these studies will provide definitive new information with regard to the basic mechanisms responsible for the cytoprotective effects of pro- inflammatory cytokines following I/R injury.
| Mann, Douglas L (2014) Colchicine and the failing heart: a ""FINER"" anti-inflammatory agent? JACC Heart Fail 2:138-40 |
| Burns, Alan R; Phillips, Sharon C; Sokoya, Elke M (2012) Pannexin protein expression in the rat middle cerebral artery. J Vasc Res 49:101-10 |
| Mann, Douglas L (2012) Sphingosine 1-phosphate as a therapeutic target in heart failure: more questions than answers. Circulation 125:2692-4 |
| Hartley, Craig J; Reddy, Anilkumar K; Madala, Sridhar et al. (2011) Doppler velocity measurements from large and small arteries of mice. Am J Physiol Heart Circ Physiol 301:H269-78 |
| Hartley, Craig J; Reddy, Anilkumar K; Madala, Sridhar et al. (2010) Feasibility of dual Doppler velocity measurements to estimate volume pulsations of an arterial segment. Ultrasound Med Biol 36:1169-75 |
| Haudek, Sandra B; Gupta, Damon; Dewald, Oliver et al. (2009) Rho kinase-1 mediates cardiac fibrosis by regulating fibroblast precursor cell differentiation. Cardiovasc Res 83:511-8 |
| Reddy, Anilkumar K; Namiranian, Khodidad; Lloyd, Eric E et al. (2009) Effect of isoflurane on aortic impedance in mice. Conf Proc IEEE Eng Med Biol Soc 2009:1104-5 |
| Divakaran, Vijay; Adrogue, Julia; Ishiyama, Masakuni et al. (2009) Adaptive and maladptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading. Circ Heart Fail 2:633-42 |
| Wu, Huaizhu; Gower, R Michael; Wang, Hong et al. (2009) Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia. Circulation 119:2708-17 |
| Liu, Xiuping; Zuo, Yumei; Zhang, Weina et al. (2009) Expression of interleukin-15 and its receptor on the surface of stimulated human umbilical vein endothelial cells. J Huazhong Univ Sci Technolog Med Sci 29:527-34 |
Showing the most recent 10 out of 219 publications
